Researchers put the predictive power of whole genome sequencing to the test.
Daily News Roundup
Researchers put the predictive power of whole genome sequencing to the test.
Once a promising cancer treatment, the failure of PARP inhibitors in the clinic may be due to flawed preclinical studies.
A new report outlines ways in which omics-based technologies can be shuttled more safely and effectively from the bench to the clinic.
Mice “avatars” grafted with patient tumor tissue help identify effective drug regimens.
One biopsy may not provide enough information about the array of mutations in cancer to devise treatments based on a tumor’s genetic profile.
Early experiments show that a hybrid form of the common pain reliever can effectively inhibit the growth of many tumor types.
A chemotherapy medication designed to kill cancer may prevent neuronal death after stroke, according to a study in mice.
UPenn has filed suit against the president of the Memorial Sloan-Kettering Cancer Center for failing to share intellectual property he developed while at the university.
Researchers find the first evidence that a sirtuin gene prolongs life in mice.
Chromosomes accidentally stranded outside of the nucleus could contribute to cancer formation.